Aortic Stenosis News and Research RSS Feed - Aortic Stenosis News and Research

Experts to discuss use of holograms and 3D printing at EuroEcho-Imaging 2016

Experts to discuss use of holograms and 3D printing at EuroEcho-Imaging 2016

EuroEcho-Imaging 2016 brings advanced techniques to the bedside with international experts set to discuss the use of holograms and 3D printing to guide interventions. [More]
Heart Valve Voice report sets out recommendations to prioritise development of NICE heart valve disease guidelines

Heart Valve Voice report sets out recommendations to prioritise development of NICE heart valve disease guidelines

UK charity Heart Valve Voice today launches its report, ‘Towards a Heart Healthy Future: a 2020 Vision for Heart Valve Disease’ at a parliamentary event attended by MPs across the country. [More]
Study reveals risk factors and outcomes of infective endocarditis after TAVR

Study reveals risk factors and outcomes of infective endocarditis after TAVR

Among patients undergoing transcatheter aortic valve replacement, younger age, male sex, history of diabetes mellitus, and moderate to severe residual aortic regurgitation were significantly associated with an increased risk of infective endocarditis, and patients who developed endocarditis had high rates of in-hospital mortality and 2-year mortality, according to a study appearing in the September 13 issue of JAMA. [More]
PinnacleHealth replaces aortic valve in two patients using minimally invasive surgery

PinnacleHealth replaces aortic valve in two patients using minimally invasive surgery

This week, PinnacleHealth became the first hospital in the country to implant the EDWARDS INTUITY Elite valve, a rapid deployment device for surgical aortic valve replacement, after U.S. Food and Drug Administration approval. [More]
Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris [tissue and plaque] dislodged during the procedure) reduced the number and volume of brain lesions, according to a study appearing in the August 9 issue of JAMA. [More]
SAPIEN 3 trans-catheter aortic valve replacement system improves survival in patients with aortic stenosis

SAPIEN 3 trans-catheter aortic valve replacement system improves survival in patients with aortic stenosis

Overall one-year survival was over 85 percent for high-risk or inoperable patients who underwent aortic valve replacement with the SAPIEN 3 trans-catheter aortic valve replacement system, according to a study published in the July 12 issue of the American Heart Association journal Circulation. [More]
Clinical study examines new treatment option for aortic stenosis patients with larger valve structure

Clinical study examines new treatment option for aortic stenosis patients with larger valve structure

A clinical trial exploring a new minimally invasive treatment option for some patients with severe aortic stenosis recently launched at Baylor Jack and Jane Hamilton Heart and Vascular Hospital. [More]
UTHealth researchers examine effectiveness of Sapien 3 TAVR in low-risk patients with aortic stenosis

UTHealth researchers examine effectiveness of Sapien 3 TAVR in low-risk patients with aortic stenosis

The Structural Heart Program team at McGovern Medical School at The University of Texas Health Science Center at Houston is among the first in the country to investigate the safety and effectiveness of Edwards Lifesciences Sapien 3 transcatheter aortic heart valve in low surgical risk patients who suffer from severe aortic valve disease. [More]
Unidentified valvular heart disease very common in elderly

Unidentified valvular heart disease very common in elderly

Over half of community-living elderly people are likely to have valvular heart disease, show findings of OxVALVE-PCS. [More]
Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Aortic stenosis means narrowing of the aortic valve, which is the out flow valve from the left ventricle, the pumping chamber of the heart. This is the valve which opens to allow blood to flood out of the heart and all-round the body. [More]
Persistent low flow warns of mortality risk after TAVR

Persistent low flow warns of mortality risk after TAVR

Patients with persistent low flow at discharge after transcatheter aortic valve replacement have an increased risk of dying during the subsequent year, report researchers. [More]
Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Aortic stenosis (AS), the narrowing of the aortic valve in the heart which causes restricted blood flow, is one of the most common and serious valve disease problems. For patients with one type of AS - low flow - transcatheter aortic valve replacement (TAVR), a minimally invasive procedure which corrects the damaged aortic valve, is often the best option for restoring the heart's normal pumping function. [More]
Mayo researchers develop extremely precise assay to measure age-associated changes in GDF11

Mayo researchers develop extremely precise assay to measure age-associated changes in GDF11

Researchers at Mayo Clinic have developed an accurate way to measure a circulating factor, called GDF11, to better understand its potential impact on the aging process. [More]
TAVI matches SAVR for early and midterm mortality

TAVI matches SAVR for early and midterm mortality

Transcatheter aortic valve implantation has similar early and midterm mortality to surgical aortic valve replacement in patients with aortic stenosis, including those at low to intermediate risk, show results of a systematic review and meta-analysis. [More]
Health of 1 million over 65s at risk from low awareness of heart valve disease

Health of 1 million over 65s at risk from low awareness of heart valve disease

New research has revealed that the UK’s over 60s could seriously be jeopardising their health due to a lack of awareness of heart valve disease. [More]

Study estimates half of transcatheter heart valves undergo degeneration within 10 years

Half of transcatheter heart valves may undergo degeneration within 10 years, according to estimates from the first study investigating the long-term durability of these valves in patients undergoing transcatheter aortic valve implantation (TAVI) reported at EuroPCR 2016. [More]
RDAVR system improves survival of patients with severe aortic stenosis

RDAVR system improves survival of patients with severe aortic stenosis

When replacing a defective aortic valve with a new one, restoring function is the first priority. However, variables such as durability, length of surgery, duration of heart stoppage, size of the surgical incision, postoperative pain, and complications are other important considerations. [More]
Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

A new study finds the use of moderate sedation, in which patients do not need a breathing tube, leads to better clinical outcomes as compared to general anesthesia for patients undergoing transcatheter aortic valve replacement (TAVR). [More]

TAVR procedure could provide improved health outcomes for inoperable patients

A novel procedure for heart valve replacement surgery could provide improved health outcomes for patients who cannot have open heart surgery, as well as being a cost effective alternative. [More]

LivaNova announces first implant of Perceval sutureless valve in PERSIST-AVR trial

LivaNova, PLC, a global medical technology company, announced today the first implant of the Perceval sutureless valve in the PERSIST-AVR trial at CHU Brabois, University of Lorraine, Nancy, France. [More]
Advertisement
Advertisement